Review




Structured Review

STEMCELL Technologies Inc rosettesep kit
Rosettesep Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rosettesep+cd3++negative+selection/rosettesep+kit/pmc05025899-34-9-14
Average 90 stars, based on 1 article reviews
rosettesep kit - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Purification:

Article Title: Targeting IL13Rα2 in melanoma with a bispecific T-cell engager: expression profiling and preclinical evaluation.
Article Snippet: .. We thank Emily Cento, Zhilin Chen, Max A Eldabbas, and Emileigh Maddox of the Human Immunology Core and the Division of Transfusion Medicine and Therapeutic Pathology at the Perelman School of Medicine at the University of Pennsylvania for providing de- identified, human PBMCs and T cells that were purified from healthy donor apheresis using StemCell RosetteSep kits. ..

Isolation:

Article Title: Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin
Article Snippet: .. CD3 + T cells were isolated by negative selection using RosetteSep Kits from STEMCELL Technologies and obtained from the Human Immunology Core at the Perelman School of Medicine at the University of Pennsylvania. .. CD3 + T cells were isolated by negative selection using RosetteSep Kits from STEMCELL Technologies and obtained from the Human Immunology Core at the Perelman School of Medicine at the University of Pennsylvania.

Article Title: Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer
Article Snippet: .. Cell Lines and Culture Blood samples were obtained from the Human Immunology Core of the University of Pennsylvania where peripheral blood CD4+ T cells were negatively isolated using RosetteSep Kits (Stem cell Technologies). ..

Article Title: Redefining the role of IL-18 in post-surgical recovery and sepsis: a key mediator of inflammation resolution.
Article Snippet: .. Monocytes were isolated from 8 mL patient blood collected from ORT patients at the appropriate time points and enriched with the RosetteSep kit (STEMCELL Technologies, Vancouver, Canada) according to the manufacturer’s instructions. .. The blood was layered on Lymphoprep® (Alere Technologies AS, Oslo, Norway) (density 1.077 g/mL) and centrifuged at 1200 g at 20 °C for 20 min. To isolate monocytes from healthy donors, buffy coats (~ 40 mL) were processed via the same method as above.

Article Title: Modified immune cells having enhanced function and methods for screening the same
Article Snippet: .. Primary human lymphocytes: Primary human CD4 and CD8 T cells were isolated from healthy volunteer donors following leukapheresis by negative selection using RosetteSep kits (Stem Cell Technologies, Vancouver BC, Canada). .. Primary lymphocytes were stimulated with anti-CD3/CD28 Dynabeads (Life Technologies, Grand Island, NY).

Selection:

Article Title: Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin
Article Snippet: .. CD3 + T cells were isolated by negative selection using RosetteSep Kits from STEMCELL Technologies and obtained from the Human Immunology Core at the Perelman School of Medicine at the University of Pennsylvania. .. CD3 + T cells were isolated by negative selection using RosetteSep Kits from STEMCELL Technologies and obtained from the Human Immunology Core at the Perelman School of Medicine at the University of Pennsylvania.

Article Title: QuickProt: A bioinformatics and visualization tool for DIA and PRM mass spectrometry-based proteomics datasets
Article Snippet: .. Briefly, CD34 + cells from umbilical cord blood donors were enriched by negative selection using the RosetteSep kit (STEMCELL Technologies; Catalog number: 15631) and the Ficoll density gradient, followed by positive selection with the Positive Selection Kit (STEMCELL Technologies, Catalog number: 18096). ..

Article Title: Modified immune cells having enhanced function and methods for screening the same
Article Snippet: .. Primary human lymphocytes: Primary human CD4 and CD8 T cells were isolated from healthy volunteer donors following leukapheresis by negative selection using RosetteSep kits (Stem Cell Technologies, Vancouver BC, Canada). .. Primary lymphocytes were stimulated with anti-CD3/CD28 Dynabeads (Life Technologies, Grand Island, NY).



Similar Products

90
STEMCELL Technologies Inc rosettesep cd3+ negative selection
Rosettesep Cd3+ Negative Selection, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rosettesep+cd3++negative+selection/rosettesep+negative+selection+system/pm36419471-143-11-18
Average 90 stars, based on 1 article reviews
rosettesep cd3+ negative selection - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc rosettesep cd3 + negative selection
Clone 7M16A binds to the extracellular domain of PAG (A) ELISA with immobilized PAG peptide (human, mouse, or cynomolgus) using hybridoma supernatants. (B) 7M16A staining of non-permeabilized wild-type C57BL6 or PAG knockout (KO) murine splenocytes shows specificity of binding. (C) Western blot of A549 cells made to stably overexpress PAG-GFP. (D) Western blot of fractionated cell lysates showing that PAG-GFP is expressed at high levels at the cell membrane. Confocal imaging showing the localization of PAG-GFP at the plasma membrane. (E) 7M16A staining of non-permeabilized A549 cells shows binding to PAG-GFP on the surface. (F) ELISA with immobilized human PAG peptide using purified monoclonal antibodies. (G) ELISA of IL-2 secretion from primary human <t>CD3</t> + T cells stimulated as indicated for 48 h. n = 3; ∗p ≤ 0.05 and ∗∗p ≤ 0.01. (H and I) Jurkat T cells stably express PAG-GFP with or without PD-1-SNAP incubated with Raji B cells in the presence of SEE. Cells were imaged using confocal microscopy to assess the location of PAG and PD-1 relative to the immune synapse. White arrow indicates the center of the immune synapse where PAG was excluded with 7M16A pretreatment. White star indicates the point in the cell with enrichment of PD-1 either at or away from the immune synapse. Quantification of the number of cells per phenotype. ∗p ≤ 0.05.
Rosettesep Cd3 + Negative Selection, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rosettesep+cd3++negative+selection/rosettesep+negative+selection+system/pmc09664140-178-12-20
Average 90 stars, based on 1 article reviews
rosettesep cd3 + negative selection - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc rosettesep cd3+ negative selection enrichment cocktail
Clone 7M16A binds to the extracellular domain of PAG (A) ELISA with immobilized PAG peptide (human, mouse, or cynomolgus) using hybridoma supernatants. (B) 7M16A staining of non-permeabilized wild-type C57BL6 or PAG knockout (KO) murine splenocytes shows specificity of binding. (C) Western blot of A549 cells made to stably overexpress PAG-GFP. (D) Western blot of fractionated cell lysates showing that PAG-GFP is expressed at high levels at the cell membrane. Confocal imaging showing the localization of PAG-GFP at the plasma membrane. (E) 7M16A staining of non-permeabilized A549 cells shows binding to PAG-GFP on the surface. (F) ELISA with immobilized human PAG peptide using purified monoclonal antibodies. (G) ELISA of IL-2 secretion from primary human <t>CD3</t> + T cells stimulated as indicated for 48 h. n = 3; ∗p ≤ 0.05 and ∗∗p ≤ 0.01. (H and I) Jurkat T cells stably express PAG-GFP with or without PD-1-SNAP incubated with Raji B cells in the presence of SEE. Cells were imaged using confocal microscopy to assess the location of PAG and PD-1 relative to the immune synapse. White arrow indicates the center of the immune synapse where PAG was excluded with 7M16A pretreatment. White star indicates the point in the cell with enrichment of PD-1 either at or away from the immune synapse. Quantification of the number of cells per phenotype. ∗p ≤ 0.05.
Rosettesep Cd3+ Negative Selection Enrichment Cocktail, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rosettesep+cd3++negative+selection/negative+selection+kits+rosettesep+human+cd8+++t+cell+enrichment+cocktail/pm28445076-27-0-6
Average 90 stars, based on 1 article reviews
rosettesep cd3+ negative selection enrichment cocktail - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Clone 7M16A binds to the extracellular domain of PAG (A) ELISA with immobilized PAG peptide (human, mouse, or cynomolgus) using hybridoma supernatants. (B) 7M16A staining of non-permeabilized wild-type C57BL6 or PAG knockout (KO) murine splenocytes shows specificity of binding. (C) Western blot of A549 cells made to stably overexpress PAG-GFP. (D) Western blot of fractionated cell lysates showing that PAG-GFP is expressed at high levels at the cell membrane. Confocal imaging showing the localization of PAG-GFP at the plasma membrane. (E) 7M16A staining of non-permeabilized A549 cells shows binding to PAG-GFP on the surface. (F) ELISA with immobilized human PAG peptide using purified monoclonal antibodies. (G) ELISA of IL-2 secretion from primary human CD3 + T cells stimulated as indicated for 48 h. n = 3; ∗p ≤ 0.05 and ∗∗p ≤ 0.01. (H and I) Jurkat T cells stably express PAG-GFP with or without PD-1-SNAP incubated with Raji B cells in the presence of SEE. Cells were imaged using confocal microscopy to assess the location of PAG and PD-1 relative to the immune synapse. White arrow indicates the center of the immune synapse where PAG was excluded with 7M16A pretreatment. White star indicates the point in the cell with enrichment of PD-1 either at or away from the immune synapse. Quantification of the number of cells per phenotype. ∗p ≤ 0.05.

Journal: Molecular Therapy. Methods & Clinical Development

Article Title: Neutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growth

doi: 10.1016/j.omtm.2022.10.012

Figure Lengend Snippet: Clone 7M16A binds to the extracellular domain of PAG (A) ELISA with immobilized PAG peptide (human, mouse, or cynomolgus) using hybridoma supernatants. (B) 7M16A staining of non-permeabilized wild-type C57BL6 or PAG knockout (KO) murine splenocytes shows specificity of binding. (C) Western blot of A549 cells made to stably overexpress PAG-GFP. (D) Western blot of fractionated cell lysates showing that PAG-GFP is expressed at high levels at the cell membrane. Confocal imaging showing the localization of PAG-GFP at the plasma membrane. (E) 7M16A staining of non-permeabilized A549 cells shows binding to PAG-GFP on the surface. (F) ELISA with immobilized human PAG peptide using purified monoclonal antibodies. (G) ELISA of IL-2 secretion from primary human CD3 + T cells stimulated as indicated for 48 h. n = 3; ∗p ≤ 0.05 and ∗∗p ≤ 0.01. (H and I) Jurkat T cells stably express PAG-GFP with or without PD-1-SNAP incubated with Raji B cells in the presence of SEE. Cells were imaged using confocal microscopy to assess the location of PAG and PD-1 relative to the immune synapse. White arrow indicates the center of the immune synapse where PAG was excluded with 7M16A pretreatment. White star indicates the point in the cell with enrichment of PD-1 either at or away from the immune synapse. Quantification of the number of cells per phenotype. ∗p ≤ 0.05.

Article Snippet: Primary human CD3 + T cells were purified from peripheral blood using RosetteSep CD3 + Negative Selection (catalog no. 15021; Stemcell) followed by Lymphoprep separation.

Techniques: Enzyme-linked Immunosorbent Assay, Staining, Knock-Out, Binding Assay, Western Blot, Stable Transfection, Membrane, Imaging, Clinical Proteomics, Purification, Bioprocessing, Incubation, Confocal Microscopy

PAG antibody and PD-1 antibody in combination enhance T cell infiltration into MC38 tumors Immunohistochemistry of dissected tumors at the study endpoint. Sections were stained with anti-CD3 from 2 tumors per condition; representative images shown (40×) (A). (B) Quantification of CD3 + cells per high-power field (HPF; 20×) from 2 tumors per condition. ∗p ≤ 0.05.

Journal: Molecular Therapy. Methods & Clinical Development

Article Title: Neutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growth

doi: 10.1016/j.omtm.2022.10.012

Figure Lengend Snippet: PAG antibody and PD-1 antibody in combination enhance T cell infiltration into MC38 tumors Immunohistochemistry of dissected tumors at the study endpoint. Sections were stained with anti-CD3 from 2 tumors per condition; representative images shown (40×) (A). (B) Quantification of CD3 + cells per high-power field (HPF; 20×) from 2 tumors per condition. ∗p ≤ 0.05.

Article Snippet: Primary human CD3 + T cells were purified from peripheral blood using RosetteSep CD3 + Negative Selection (catalog no. 15021; Stemcell) followed by Lymphoprep separation.

Techniques: Immunohistochemistry, Staining